(Q24242339)

30 October 2023

Glenn E Hunt

2

G

Hunt

1 reference

30 October 2023

Michelle Cleary

1

M

Cleary

1 reference

30 October 2023

Sandra L Matheson

3

S

Matheson

1 reference

18253984

30 October 2023

Garry Walter

series ordinal

5

author given names

G

author last names

Walter

1 reference

18253984

Cochrane Database of Systematic Reviews

30 October 2023

language of work or name

1 reference

23 January 2008

0 references

published in

0 references

cites work

Evaluation of a motivational interview for substance use within psychiatric in-patient services

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Motivational interviewing among psychiatric in-patients with substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Integrating services for schizophrenia and substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Cost-effectiveness of substance disorder interventions for people with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

A brief motivational intervention for substance misuse in recent-onset psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

An integrated treatment program for dually diagnosed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Group cognitive-behavioural therapy for schizophrenia. Randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Treating substance abuse in schizophrenia. An initial report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Enhancing readiness-to-change substance abuse in persons with schizophrenia. A four-session motivation-based intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Reducing HIV-risk behavior among adults receiving outpatient psychiatric treatment: results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Managing MICA clients in a modified therapeutic community with enhanced staffing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Family support and substance use outcomes for persons with mental illness and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Psychiatric hospitalizations, arrests, emergency room visits, and homelessness of clients with serious and persistent mental illness: findings from a randomized trial of two ACT programs vs. usual care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

The efficacy of substance abuse education among dual-diagnosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Effects of diagnosis, demographic characteristics, and case management on rehospitalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Implementing assertive community treatment teams.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Two group therapy models for clients with a dual diagnosis of substance abuse and personality disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Modified therapeutic community for mentally ill chemical abusers: outcomes and costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Acute Ketamine Intoxication Treated by Haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Case management for dually diagnosed individuals involved in the criminal justice system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Effects of substance dependence on outcomes of patients in a randomized trial of two case management models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Service enhancement to a dual-diagnosis population: mental illness/substance abuse (MISA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Promising treatments for women with comorbid PTSD and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Immediate outcomes of substance use treatment within a state psychiatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Six-month outcomes associated with a brief alcohol intervention for adult in-patients with psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Effects of substance abuse on housing stability of homeless mentally Ill persons in supported housing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Issues and outcomes in integrated treatment programs for dual disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

A dual diagnosis demonstration project: treatment outcomes and cost analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Residential treatment for dually diagnosed homeless veterans: a comparison of program types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Major depression in patients with substance use disorders: relationship to 12-Step self-help involvement and substance use outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Motivational interviewing with psychiatrically ill substance abusing patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Service use and cost by mentally ill chemical abusers: differences by retention in a therapeutic community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

An experimental comparison of three types of case management for homeless mentally ill persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Analysis of postdischarge change in a dual diagnosis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Rural and urban differences in patients with a dual diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Characteristics and Treatment of Homeless, Mentally Ill, Chemical-Abusing Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Outcomes of a randomized small-group HIV prevention intervention trial for people with serious mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Comparing treatments for dual diagnosis: twelve-step and self-management and recovery training

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Outcomes of managing disability benefits among patients with substance dependence and severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Cost-effectiveness of intensive psychiatric community care for high users of inpatient services.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Modified TC for MICA offenders: crime outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Severely mentally ill substance abusers: an 18-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Involuntary out-patient commitment and reduction of violent behaviour in persons with severe mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Evaluating use of continuous treatment teams for persons with mental illness and substance abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Short-term outcomes of matching dual diagnosis patients' symptom severity to treatment intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group-based modeling approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Integrated drug and alcohol intervention: development of an opportunistic intervention program to reduce alcohol and other substance use among psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Negative symptoms in schizophrenia. Definition and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Statistics notes. Trials randomised in clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

The role of twelve-step approaches in dual diagnosis treatment and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Assertive community treatment for frequent users of psychiatric hospitals in a large city: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

The assessment of insight in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

The unit of analysis error in studies about physicians' patient care behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Issues in the meta-analysis of cluster randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

The course, treatment, and outcome of substance disorder in persons with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Review of integrated mental health and substance abuse treatment for patients with dual disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

A Review of Treatments for People with Severe Mental Illnesses and Co-Occurring Substance Use Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Revising axis V for DSM-IV: a review of measures of social functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Selecting a rating scale for evaluating services to the chronically mentally ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Reasons for increased substance use in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Cognitive behaviour therapy for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

The British experience of dual diagnosis in the national health service.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

The Fifth Edition of the Addiction Severity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Development of a schizophrenia scale sensitive to change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Clinical interventions for severe mental illness and co-occurring substance use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Defining dual diagnosis of mental illness and substance misuse: some methodological issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

The reliability and validity of the SAS-SMI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

SCAN. Schedules for Clinical Assessment in Neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Treatment for the Dually Diagnosed Homeless

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

Nonspecific psychological distress and other dimensions of psychopathology. Measures for use in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Cost-effective treatment for persons with dual disorders.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

The challenge of treating forensic dual diagnosis clients: comment on "integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders".

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Role of self-help processes in achieving abstinence among dually diagnosed persons.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Initiating abstinence in cocaine abusing dually diagnosed homeless persons

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Social class, psychological disorder, and the nature of the psychopathologic indicator

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Screening depressed patients in family practice. A rapid technic

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Cognitive behavior therapy for schizophrenia in patients with mild to moderate substance misuse problems

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Rehabilitation for adults with severe mental illness and substance use disorders. A clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Treatment of substance abuse in severely mentally ill patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

A scale for assessing the stage of substance abuse treatment in persons with severe mental illness.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

A comprehensive psychopathological rating scale

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Increasing treatment adherence among outpatients with depression and cocaine dependence: results of a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Clinical case management, case management, and ACT

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Motivational interviewing and clinical psychiatry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

A review of comorbidity: major mental illness and problematic substance use

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001088.PUB2

7 January 2021

Case management for people with severe mental disorders.

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD000050

Identifiers

DOI

10.1002/14651858.CD001088.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

5763

Fatcat ID

release_mhaehcrqozhj7labuddn3lb53u

0 references

OpenCitations bibliographic resource ID

5763

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

5763